XML 25 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 02, 2024
Dec. 31, 2024
Oct. 01, 2024
Dec. 31, 2025
Dec. 31, 2024
Cash Flows Used in Operating Activities          
Net Loss   $ (70,093,000) $ (28,198,000) $ (475,350,000)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation   16,338,000 1,056,000 27,872,000  
Interest income on debt securities - related party   (106,000) (110,000) (394,000)  
Change in fair value of financial liabilities   20,946,000 478,000 (16,146,000)  
Write-off of loan commitment fee asset   10,041,000 0 0  
Non-cash interest expense on notes payable   248,000 351,000 6,588,000  
Accrued unpaid interest on note payable   69,000 930,000 336,000  
Equity method investment loss (income)   902,000 (893,000) 12,592,000  
Realized gain on conversion of available for sale investments   0 0 (1,507,000)  
Loss on conversion of promissory notes   0 1,119,000 0  
Deferred income taxes   (3,301,000) 432,000 (13,450,000)  
Depreciation and amortization   5,455,000 146,000 22,506,000  
Goodwill impairment   0 0 346,557,000 $ 0
Other costs, net   64,000 185,000 195,000  
Changes in operating assets and liabilities:          
Accounts receivable   (166,000) (117,000) (811,000)  
Prepaid expenses and other current assets   (1,301,000) (1,353,000) (11,676,000)  
Inventory   (2,354,000) (2,824,000) 3,574,000  
Accounts payable   (11,211,000) 6,013,000 (1,392,000)  
Accrued employee benefits   1,656,000 3,838,000 1,727,000  
Accrued expenses   (484,000) 674,000 (480,000)  
Stock-based compensation liability   1,160,000 0 (921,000)  
Income taxes payable   0 0 23,000  
Other current liabilities   (77,000) (146,000) (358,000)  
Contract liabilities   0 0 947,000  
Obligation to issue equity   3,000,000 10,920,000 0  
Other assets   0 (20,000) (61,000)  
Patent installment payable   0 (250,000) (525,000)  
Net Cash Used in Operating Activities   (29,214,000) (18,848,000) (80,683,000)  
Cash Flows (Used in) Provided by Investing Activities          
Advances to equity method investee   (4,240,000) (135,000) 0  
Acquisition of property, plant and equipment   (266,000) (736,000) (1,417,000)  
Acquisition of intangible assets   (30,000) 0 0  
Acquisition of net assets, net of cash acquired, through business combination   16,000 0 0  
Proceeds from sale of investments   0 2,314,000 0  
Cash withdrawn from trust as a result of business combination $ 11,342,000 11,342,000 0 0  
Net Cash (Used in) Provided by Investing Activities   6,822,000 (5,957,000) (4,125,000)  
Cash Flows Provided by Financing Activities          
Proceeds from issuance of equity, net of issuance costs   15,383,000 13,122,000 12,654,000  
Proceeds from the issuance of equity to non-controlling interest, net of issuance costs   4,169,000 13,859,000 71,377,000  
Distributions to Stockholders   (663,000) 0 (76,000)  
Cash Flows Provided by Financing Activities   33,466,000 38,441,000 139,138,000  
Net Increase in Cash, Cash Equivalents and Restricted Cash   11,074,000 13,636,000 54,330,000  
Cash, Cash Equivalents and Restricted Cash Beginning of period 45,000 45,000 2,575,000 11,119,000 2,575,000
Cash, Cash Equivalents and Restricted Cash End of period   11,119,000 45,000 65,449,000 $ 11,119,000
Supplemental Cash Flow Information          
Cash paid for interest   991,000 1,070,000 0  
Supplemental Disclosure of Noncash Financing Information          
Accretion of redeemable units to redemption value   0 11,950,000 0  
Debt discount and embedded derivative upon issuance   0 0 0  
Issuance of units to non-controlling interest in exchange of convertible promissory notes   0 7,324,000 0  
Conversion of working capital loans to equity method investees into investments in debt securities - related party   0 2,600,000 4,375,000  
Transfer of liability warrants to equity warrants in the Business Combination   1,265,000 0 0  
Initial recognition of loan commitment fee   16,190,000 0  
Transfer of loan commitment fee asset   6,694,000 0 0  
Recognition of right of use asset and corresponding lease liability   0 0 927,000  
Extinguishment of debt with Series C Preferred Stock   0 0 14,000,000  
Contribution of Series C Preferred Stock to equity method investee   0 0 5,783,000  
Conversion of AFX available-for-sale term loan into equity method investments   0 0 8,757,000  
Issuance of common stock as repayment of convertible debt   0 0 47,000,000  
Issuance of stock in exchange for services   250,000 0 4,102,000  
Conversion of preferred stock into common stock   0 0 36,910,000  
Transfer of Series C Preferred Stock from Mezzanine to Stockholders' equity   0 0 1,440,000  
Embedded derivative in association with Convertible Debentures   0 0 1,774,000  
Equity reallocation between non-controlling interest and additional paid-in capital   0 0 36,963,000  
Embedded derivative liability derecognition   0 0 3,297,000  
Previously Reported          
Cash Flows Provided by Financing Activities          
Cash, Cash Equivalents and Restricted Cash Beginning of period $ 16,211,000 16,211,000      
Cash, Cash Equivalents and Restricted Cash End of period     16,211,000    
Related party          
Adjustments to reconcile net loss to net cash used in operating activities:          
Net gain on investments   0 468,000 0  
Loss on extinguishment of debt   0 0 3,538,000  
Cash Flows (Used in) Provided by Investing Activities          
Investment in debt securities   0 (7,400,000) 0  
Cash Flows Provided by Financing Activities          
Proceeds from the issuance of related party convertible promissory notes and term convertible notes   0 0 4,350,000  
Proceeds from issuance of debt securities, net of issuance costs   0 12,000,000 0  
Payment of debts   (4,628,000) 0 0  
Nonrelated party          
Adjustments to reconcile net loss to net cash used in operating activities:          
Net gain on investments   0 (11,547,000) (131,000)  
Loss on extinguishment of debt   0 0 16,064,000  
Cash Flows (Used in) Provided by Investing Activities          
Investment in debt securities   0 0 (2,708,000)  
Cash Flows Provided by Financing Activities          
Proceeds from the issuance of related party convertible promissory notes and term convertible notes   0 0 14,950,000  
Proceeds from issuance of debt securities, net of issuance costs   19,455,000 0 40,500,000  
Payment of debts   $ (250,000) $ (540,000) $ (4,617,000)